Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dag Veimo"'
Autor:
Hervé Dumas, Lotta Johansson, Dag Veimo, Shirley Langham, Fritz Haverkamp, Francesco Chiarelli, Maithé Tauber
Publikováno v:
Clinical Therapeutics. 30:307-316
Background: The effectiveness of all prescribed treatments is contingent on patient adherence. The reported levels of adherence to recombinant human growth hormone (r-hGH) therapy are highly variable, but it has been suggested that nonadherence might
Autor:
Klaus Mohnike, Stefan Aronson, Lo Neumeyer, Ilkka Sipilä, Martin Ritzén, Dag Veimo, Jørn Müller, Sten A. Ivarsson, Ole Eklöf, Otto Westphal, Jon Bland, Lars Hagenäs, Ilkka Kaitila, Niels Thomas Hertel
Publikováno v:
Acta Paediatrica. 94:1402-1410
Background: Achondroplasia is a skeletal dysplasia with extreme, disproportionate, short stature. Aim: In a 5-y growth hormone (GH) treatment study including 1 y without treatment, we investigated growth and body proportion response in 35 children wi
Autor:
Niels Hertel, Ole Eklöf, Sten Ivarsson, Stefan Aronson, Otto Westphal, Ilkka Sipilä, Ilkka Kaitila, Jon Bland, Dag Veimo, Jørn Müller, Klaus Mohnike, Lo Neumeyer, Martin Ritzen, Lars Hagenäs
Publikováno v:
Acta paediatrica (Oslo, Norway : 1992). 94(10)
Achondroplasia is a skeletal dysplasia with extreme, disproportionate, short stature.In a 5-y growth hormone (GH) treatment study including 1 y without treatment, we investigated growth and body proportion response in 35 children with achondroplasia.
Autor:
Per M. Knappskog, Asbjørg Stray-Pedersen, Dag Veimo, Eystein S. Husebye, Anne Grethe Myhre, Steinar Spangen, Tore G. Abrahamsen, Eigill Eide
Publikováno v:
European Journal of Pediatrics.
We describe the clinical and immunological features of two families with chronic mucocutaneous candidiasis (CMC) and primary hypothyroidism. Family A includes three siblings with both candidiasis and hypothyroidism and four individuals with hypothyro